Skip to main content

Find Clinical Trials

Home
Conditions
NK-LGL Leukemia

Clinical trial condition

NK-LGL Leukemia

Explore clinical trials studying NK-LGL Leukemia. Study availability and eligibility vary by location and protocol.

5 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

NK-LGL Leukemia trial results

Recruiting

Registry of the German CLL Study Group

NCT02863692

Conditions: CLL, HCL, Hematologic Diseases, +19 more
Locations: BAG Freiberg-Richter, Jacobasch, Wolf, Illmer Dresden, Saxony, Germany

View Trial Details

Recruiting

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

NCT06530576

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

NCT06716658

Conditions: Cutaneous T Cell Lymphoma, Cutaneous T Cell Lymphoma (CTCL), Hematologic Diseases, +22 more
Locations: Institute of Hematology & Blood Diseases Hospital, China Tianjin, Tianjin Municipality, China

Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

NCT06530550

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia

NCT07019766

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Red Blood Cell Diseases Center and Regenerative Medicine Center Tianjin, Tianjin Municipality, China

View Trial Details